Dolby Laboratories $DLB Shares Bought by Sepio Capital LP

Key Points

• Sepio Capital LP increased its stake in Dolby Laboratories by 68.6% in Q1, owning 18,188 shares now valued at $1,461,000.
• Insider sales included SVP Shriram Revankar selling 7,000 shares and CEO Kevin J. Yeaman selling 25,000 shares, decreasing their holdings by 9.04% and 17.89% respectively.
• Dolby Laboratories declared a quarterly dividend of $0.33 per share, yielding 1.8%, indicating a healthy dividend payout ratio of 48.35%.

Sepio Capital LP raised its holdings in Dolby Laboratories (NYSE:DLB - Free Report) by 68.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,188 shares of the electronics maker's stock after acquiring an additional 7,403 shares during the quarter. Sepio Capital LP's holdings in Dolby Laboratories were worth $1,461,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC lifted its holdings in Dolby Laboratories by 114.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,141 shares of the electronics maker's stock valued at $975,000 after acquiring an additional 6,484 shares during the period. Park Avenue Securities LLC purchased a new position in shares of Dolby Laboratories in the first quarter valued at $222,000. Vanguard Group Inc. increased its position in shares of Dolby Laboratories by 7.1% in the first quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker's stock valued at $605,194,000 after buying an additional 502,110 shares in the last quarter. Fiera Capital Corp increased its position in shares of Dolby Laboratories by 19.0% in the first quarter. Fiera Capital Corp now owns 639,404 shares of the electronics maker's stock valued at $51,351,000 after buying an additional 102,028 shares in the last quarter. Finally, Vise Technologies Inc. purchased a new position in shares of Dolby Laboratories in the fourth quarter valued at $308,000. Institutional investors and hedge funds own 58.56% of the company's stock.

Analyst Upgrades and Downgrades

DLB has been the subject of a number of research analyst reports. Baird R W upgraded Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Tigress Financial upped their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Robert W. Baird began coverage on shares of Dolby Laboratories in a report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective on the stock. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Finally, Rosenblatt Securities reissued a "buy" rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $95.75.

Dolby Laboratories Stock Performance

Shares of NYSE DLB traded down $1.28 during trading on Wednesday, reaching $71.01. The stock had a trading volume of 389,146 shares, compared to its average volume of 433,059. Dolby Laboratories has a one year low of $68.24 and a one year high of $89.66. The stock has a market cap of $6.81 billion, a PE ratio of 26.01 and a beta of 0.93. The firm's 50 day moving average price is $73.98 and its two-hundred day moving average price is $75.69.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. During the same period in the previous year, the business earned $0.71 EPS. The business's quarterly revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is presently 48.35%.

Insiders Place Their Bets

In related news, SVP Shriram Revankar sold 7,000 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This represents a 9.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Yeaman sold 39,875 shares of the company's stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $74.82, for a total value of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 99,366 shares of company stock valued at $7,352,963. 38.39% of the stock is owned by company insiders.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.